DIA
Drug Information Association Logo

Search Posters

Search Poster Presentation 

Poster Number Poster Title Poster Type Date/Time Poster Presenter
W 01 Evaluation of Operating Characteristics of MMRM Analysis Using All Available Longitudinal Data at Interim Compared to ANCOVA Professional Wed, Jun 18 7:15AM Weining Z. Robieson
W 02 Recent Developments in Scaled Average Bioequivalence Professional Wed, Jun 18 7:15AM Pascal Guibord
W 03 An Overview of Both Current Best Available and Next Generation of Drug Therapies for the Treatment of Depression Professional Wed, Jun 18 7:15AM Annette S. Williams
W 04 Health Literacy Assessment, Usability Testing, and Revision of a European Union Risk Management Plan Public Summary Professional Wed, Jun 18 7:15AM Karen Lockwood
W 05 Coordination of a Multi-site Cell and Gene Therapy Study in an Academic Medical Center: A Success Story Professional Wed, Jun 18 7:15AM Bambi Grilley
W 06 An Innovative Way of Providing Timely Responses to Questions Related to Ingredients/Allergens Professional Wed, Jun 18 7:15AM Irene Sheng
W 07 Evaluating and Supporting the Increasing Patient Need for Delivery of Clinical Trial Supplies Direct to Their Homes Professional Wed, Jun 18 7:15AM Esther Sadler-Williams
W 08 New Business Acumen Tool Guides Strategic Thinking: Learn How to Increase Your Value to the Company and to the Industry Professional Wed, Jun 18 7:15AM Ilyssa Levins
W 09 Complexity in Protocol Design: Does it Lead to Better Clinical Trial Outcomes? Professional Wed, Jun 18 7:15AM Rebecca Hummel
W 10 Corporate Integrity Agreement and Its Impact on Industry Professional Wed, Jun 18 7:15AM Abhishek Harde
W 11 Giving Clinical Trial Start Up A Project Management Make-Over: Reducing Cycle Times Through Critical Path Focus Professional Wed, Jun 18 7:15AM Ben Quartley
W 12 The Impact of Regulatory Reform in Mexico on Pharmaceutical Product Approval Rates Professional Wed, Jun 18 7:15AM Raul M. Vinueza
W 13 So How DO You implement eSource: Practical Tips for Enhancing Efficiency, Data Visibility, and Site Interactions Professional Wed, Jun 18 7:15AM Ed Seguine
W 14 Duloxetine Feeding Tube Study: Medical Information Example of Collaboration with Laboratory Scientists to Deliver Answers. Professional Wed, Jun 18 7:15AM Andrew Scot Buchanan
W 15 Targeting the Best Sites with an Analytical Site Selection Model Using Multiple Metrics Professional Wed, Jun 18 7:15AM Elizabeth Nielsen
W 16 Central Recruitment Methodologies in a Global Clinical Research Study of a Pediatric Autism Spectrum Disorder (ASD) Program Professional Wed, Jun 18 7:15AM Allan Christopher Spera
W 17 Evaluation of Shipping Systems to Maintain Sample Integrity in Clinical Research Professional Wed, Jun 18 7:15AM Mona Vimal
W 18 A Comparison of MedDRA SMQs Relative to Individual Preferred Terms for Signal Detection on a Large Insurance Claims Database Professional Wed, Jun 18 7:15AM Christopher Bone
W 19 Introducing and Conducting Traditional Chinese Medicine Trials in the US: Challenges, Obstacles, and Potential Solutions Professional Wed, Jun 18 7:15AM John Yongbo Li
W 20 Coherence of Observed-to-Expected Disproportionality Methods Used for Pharmacovigilance at a Critical Threshold Professional Wed, Jun 18 7:15AM Geoffrey Gipson
W 21 Enhancing Project Management Tracking to Facilitate the Protocol Development Process Professional Wed, Jun 18 7:15AM Tracey Miller
W 22 Continued Tradition of Success: Critical Components of the Genzyme/Sanofi Oncology/MCPHS University Post-PharmD Fellowship Professional Wed, Jun 18 7:15AM Christina Marie Gallagher
W 23 Assessment of Violations Cited by OPDP in Untitled and Warning Letters Issued from 2004-2013 Professional Wed, Jun 18 7:15AM Phil Reveal
W 24 Accelerating Patient Recruitment Using In-Depth Market Research Insights: Collected via a 3rd Party - From Clinical Trial Site Staff Professional Wed, Jun 18 7:15AM Jeff Jamer
W 25 Implementing a Standard Report Set for Risk Based Monitoring Domains Professional Wed, Jun 18 7:15AM Christine Riley-Wagenmann
W 26 Investigation of Association Between COPD Treatment and Cardiac Events With or Without Treatment for Co-Existing Disease Professional Wed, Jun 18 7:15AM Ayako Takizawa
W 27 Reinventing the Study Build Process to Promote Consistency, Increase Build Efficiencies, and Reduce Overall Timelines Professional Wed, Jun 18 7:15AM Caroline Lin
W 28 Collaborative Development of an Open Source Repository for Standardized Analysis Using Cloud Services Professional Wed, Jun 18 7:15AM Hanming H Tu
W 29 Quality of Japanese Clinical Trials and Proposed Strategy for the Trial Sites Professional Wed, Jun 18 7:15AM Toshiyoshi Tominaga
W 30 A Collaboration to Facilitate the Development of Antibacterial Agents for Unmet Need: Streamlining Clinical Trial Protocols Professional Wed, Jun 18 7:15AM Gary Noel
W 31 Global Regulatory Considerations for Biosimilar Approval Professional Wed, Jun 18 7:15AM Holly Groelle
W 32 Impact of FDA Breakthrough Therapy Designation on the Regulatory Timelines of Chronic Lymphocytic Leukemia (CLL) Therapies Professional Wed, Jun 18 7:15AM Alex Wei
W 33 An Extension of Likelihood Ratio Test-Based Method for Signal Detection in a Drug Class with Application to FDA's AERS Database Professional Wed, Jun 18 7:15AM Yueqin Zhao
W 34 Maintaining Effective Pharmacovigilance Oversight: The Role of Remote Auditing Professional Wed, Jun 18 7:15AM Alun C Tanner
W 35 Data Empowered Decision Making in a Pharmaceutical Company: Project Libraries and Workflows - Real Life Experience Professional Wed, Jun 18 7:15AM Mikhail Samsonov
W 36 Sample Size Re-Estimation Can Be Very Inefficient Professional Wed, Jun 18 7:15AM David R. Bristol
W 37 So You Hired a CRO…Now What? Advancing Clinical Research by Leveraging Government Sponsor Relationships with CROs Professional Wed, Jun 18 7:15AM Jessica Holden Kloda
W 38 Office of Prescription Drug Promotion (OPDP) Enforcement Overview From 1997 to 2013 Professional Wed, Jun 18 7:15AM Cyril Alexandre Carrere
W 39 Enrollment of Pregnant Women in Medication Safety Research: MotherToBaby Pregnancy Studies Professional Wed, Jun 18 7:15AM Jennifer Zellner
W 40 A Model for Centralized Monitoring: Reducing Costs While Ensuring Compliance, Risk Mitigation and Quality Professional Wed, Jun 18 7:15AM Justin Stark
W 41 Customer Satisfaction and Communication Methods Used in Conducting Large Multi-Center Clinical Trials Professional Wed, Jun 18 7:15AM Barbara J. Del Curto
W 42 Easy as A,B,C? Adapting Pediatric Protocol Designs from Existing Adult Data and Study Templates Professional Wed, Jun 18 7:15AM Rona Claire Grunspan
W 43 The Construction and Promotion of Medication-Used Safety Education for Traditional Chinese Medicine in Taiwan Professional Wed, Jun 18 7:15AM Tsung-Ta Wu
W 44 Patterns of Regulatory Approval for Targeted and Immunotherapeutic Compounds Indicated for the Treatment of Metastatic Melanoma in the US and EU Professional Wed, Jun 18 7:15AM Jonathan Nguyen Diep
W 45 Retrospective Chart Review Studies: Key Considerations for Fullfilling Safety Reporting Requirements Professional Wed, Jun 18 7:15AM Dara Stein